Masaki Arimori

648 citations
12 papers · 487 indexed · h-index 6

Masaki Arimori

9 papers receiving 467 citations

Peers

Masaki Arimori
Comparison fields: 5 of 37
  • Pulmonary and Respiratory Medicine 395
  • Surgery 425
  • Gastroenterology 33
  • Oncology 82
  • Otorhinolaryngology 9
Replace N. Wang with:
N. Wang Sweden
Katsu Hirayama Japan
Paymaster Jc
Tomohiko Nishi Japan
M. Polée Netherlands
Tsunehide Boku Japan
Jun-Peng Lin China
Reiki Eguchi Japan
Cian Muldoon Ireland
Yusuke Taniyama Japan
Masaki Arimori relative to N. Wang Sweden N. Wang's profile →
Citations per field
00.5×
N. Wang · 1×
Citations per year

Countries citing papers authored by Masaki Arimori

Since Specialization
Citations

This map shows the geographic impact of Masaki Arimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Arimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Arimori more than expected).

Fields of papers citing papers by Masaki Arimori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Arimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Arimori. The network helps show where Masaki Arimori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masaki Arimori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masaki Arimori Line = papers co-authored together Masaki Arimori links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 1997215
2 19948
3 19931
4 19930
5 19930
6 1992173
7 19894
8 198855
9
[Changes in cellular immunity and their effect on pulmonary infections and prognosis after surgery of esophageal cancer patients].
19851
10
[Roentgenologic study of lesions of the cardia].
19721
11 197112
12 197017

About Masaki Arimori

Masaki Arimori is a scholar working on Gastroenterology, Speech and Hearing and Toxicology, having authored 12 papers that have together received 487 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (4 papers), Lung Cancer Treatments and Mutations (3 papers), Gastroesophageal reflux and treatments (2 papers), Dysphagia Assessment and Management (2 papers), Cancer therapeutics and mechanisms (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (395 citations), Surgery (425 citations) and Gastroenterology (33 citations). Masaki Arimori has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Teruo Kakegawa, Nobutoshi Ando, Toshifumi Iizuka, Hiroko Ide, Iwao Takagi, Hiroshi Watanabe, Kaoru Ishida, K Isono, Wataru Takiyama and Shoichiro Tsugane. Their work appears in journals such as Japanese Journal of Clinical Oncology, CHEST Journal, Journal of Thoracic and Cardiovascular Surgery, Journal of Surgical Oncology and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026